The data highlights Sweden as the leader in R&D expenditure in human health activities per capita, even though it remained static into 2023. Notably, Slovakia saw the highest year-on-year growth at 44.51% among the listed countries. Finland recorded a significant increase of 28.65%, while Italy and Portugal exhibited moderate growth of 4.39% and 19.23%, respectively. In contrast, the Czech Republic experienced an 11.68% decline. Over five years, the variances suggest dynamic changes, with evident disparities among European nations in their commitment to this sector.
Future trends to watch include increasing investments from Nordic countries and significant fluctuation in Central and Eastern Europe, indicative of regional policy shifts and prioritization of health innovation. Monitoring shifts in public-private partnerships and international collaborations in healthcare R&D will be essential in understanding these trends further.
Top countries in Business Expenditure on R&D in Human Health Activities by Country
| # | 10 Countries | Euros Per Capita | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Sweden | 18.49 | 2023 | +23.24% | View data | |
| 2 | 2 Finland | 8.44 | 2023 | +17.93% | +28.65% | View data |
| 3 | 3 Spain | 6.24 | 2021 | View data | ||
| 4 | 4 Italy | 5.41 | 2023 | +6.16% | +4.39% | View data |
| 5 | 5 Hungary | 4.97 | 2021 | View data | ||
| 6 | 6 Portugal | 4.57 | 2023 | +6.48% | +19.23% | View data |
| 7 | 7 Croatia | 4.03 | 2023 | +44.32% | View data | |
| 8 | 8 Slovakia | 3.25 | 2023 | +8.36% | +44.51% | View data |
| 9 | 9 Malta | 1 | 2023 | +6.85% | View data | |
| 10 | 10 Czech Republic | 0.15 | 2023 | -13.22% | -11.68% | View data |
